Sitemap
March 30, 2014 Articles
Filter by Available Specialty
- AleCardio data do not support use of aleglitazar for CV risk reduction
- ASH presents ‘bridge grants’ to 15 hematology researchers
- CHOICE: High device success rate with Sapien XT transcatheter valve
- Evolocumab shows promise in GAUSS-2, LAPLACE-2 trials
- EXAMINE: Alogliptin showed no effect on CV mortality, HF hospitalization
- FDA clears toe restoration system
- Global SYMPLICITY registry reveals low rate of adverse events with renal denervation system
- High-sensitivity cardiac troponin T predicted patients with chest pain at minimal risk
- MADIT-CRT: CRT-D linked to long-term survival benefit in patients with LBBB
- Melody TPV shows promising results in post-approval study
- Policy report asks for more US government involvement in global health research and development
- STABILITY: Darapladib misses primary endpoint in stable CHD population